Topic
7 articles on longevity-treatments in longevity medicine. View all news →
NAD+ therapy clinics now sell IV NAD+, IV NR, NMN, and oral NR protocols. Here is the evidence, safety, regulatory context, costs, and buyer checklist for 2026.
IV nutrient therapy can be clinically useful for selected deficiencies, but anti-aging claims are weaker. Here is how to compare clinics, costs, and safety protocols.
Peptide therapy is the fastest-growing treatment category at longevity clinics. But RFK Jr.'s push to reclassify 12 banned peptides has created confusion. Here's which peptides clinics actually use, what the evidence says, what they cost, and how to choose a clinic.
Niagen Bioscience is partnering with OneSpaWorld to offer pharmaceutical-grade NAD+ IV therapy at 80+ medi-spa clinics on high-end cruise ships starting summer 2026. Is this democratization or dilution of longevity medicine?
HHS Secretary Kennedy announced ~14 peptides will move from Category 2 (restricted) to Category 1 (legal for compounding). Here's what the reclassification means for longevity medicine, which peptides are returning, and why physician oversight matters more than ever.
Stem cell therapy for aging jumped from $29.9B (2025) to $31.8B (2026), with allogeneic MSCs dominating. But which clinics offer the best programs? This guide compares top destinations by cell type, protocol, safety, and cost.
Therapeutic plasma exchange (TPE) is having its moment: Joe Rogan tried it, longevity clinics are adding it to their menus, and a Buck Institute trial showed 2.6-year biological age reduction. But what is it, what does the science say, and where can you actually get it?